Three Key Indices in Clinical Practice to Better Comprehend the Postprandial and Basal Glucose Contributions in Type 2 Diabetes

Diabetes Technology & TherapeuticsVol. 24, No. 11 CommentaryThree Key Indices in Clinical Practice to Better Comprehend the Postprandial and Basal Glucose Contributions in Type 2 DiabetesLouis Monnier, Claude Colette, and David OwensLouis MonnierAddress correspondence to: Louis Monnier, MD, Medical School of Montpellier, University of Montpellier, 641 Avenue Du Doyen Giraud, Montpellier 34093, cedex 5, France E-mail Address: louis.monnier@inserm.frhttps://orcid.org/0000-0003-3843-0308Medical School of Montpellier, University of Montpellier, Montpellier, France.Search for more papers by this author, Claude ColetteMedical School of Montpellier, University of Montpellier, Montpellier, France.Search for more papers by this author, and David Owenshttps://orcid.org/0000-0003-1002-1238Diabetes Research Unit, University of Swansea Medical School, Swansea, Wales, United Kingdom.Search for more papers by this authorPublished Online:31 Oct 2022https://doi.org/10.1089/dia.2022.0286AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 24Issue 11Nov 2022 InformationCopyright 2022, Mary Ann Liebert, Inc., publishersTo cite this article:Louis Monnier, Claude Colette, and David Owens.Three Key Indices in Clinical Practice to Better Comprehend the Postprandial and Basal Glucose Contributions in Type 2 Diabetes.Diabetes Technology & Therapeutics.Nov 2022.853-855.http://doi.org/10.1089/dia.2022.0286Published in Volume: 24 Issue 11: October 31, 2022Online Ahead of Print:October 4, 2022Online Ahead of Editing: September 12, 2022PDF download